Technical analysis of Protagonist Therapeutics, Inc. (PTGX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Protagonist Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering and advancing peptide-based therapies. Their research primarily focuses on treatments for hematological and blood conditions, as well as inflammatory and immune-mediated disorders.
Price Performance
| 1 month | -9.22% |
| 3 months | +26.56% |
| Year-to-date | +63.54% |
| 1 year | +141.20% |
| 3 years | +709.29% |
| 5 years | +714.83% |
52-Week Range
| 52-week High | $160.81 |
| 52-week Low | $57.90 |
| Avg Volume (90d) | 634K |
Technical Indicators
| SMA 50 | $143.46 |
| SMA 200 | $108.12 |
| Beta | 2.11 |
| 30-day Volatility (annualised) | 33.3% |
| Price vs SMA 50 | -0.4% |
| Price vs SMA 200 | +32.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $78.62 | |
| 2025-11 | $90.00 | +14.5% |
| 2025-12 | $87.34 | -3.0% |
| 2026-01 | $81.80 | -6.3% |
| 2026-02 | $92.08 | +12.6% |
| 2026-03 | $105.40 | +14.5% |
| 2026-04 | $98.97 | -6.1% |
| 2026-05 | $99.56 | +0.6% |
| 2026-06 | $122.58 | +23.1% |
| 2026-07 | $136.64 | +11.5% |
| 2026-08 | $147.75 | +8.1% |
| 2026-09 | $142.84 | -3.3% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $142.84 |
| Market Cap | $9.2B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 8.71 |
| EV / EBITDA | -42.43 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.02 |
| Current Ratio | 12.71 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 59.63 |